Decoy Therapeutics, Inc. (DCOY)

3.06 +0.01 (+0.33%) USD  |  NASDAQ  |  Sep 01, 16:00
3.08 +0.02 (+0.65%) After-Hours: 20:00
More

Decoy Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for DCOY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
September 09, 2024 --
August 14, 2024 --
April 02, 2024 --
February 13, 2024 --
November 13, 2023 --
November 10, 2023 --
August 14, 2023 --
July 14, 2023 --
Date Value
July 11, 2023 --
June 14, 2023 --
May 15, 2023 --
May 11, 2023 --
April 24, 2023 --
March 29, 2023 --
March 09, 2023 --
February 16, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Palatin Technologies, Inc. Upgrade
Unicycive Therapeutics, Inc. Upgrade
Nuvectis Pharma, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade